Drug news
Astellas withdraws from tivozanib collaboration with Aveo Pharma in Europe
Aveo Pharmaceuticals Inc reported that it was informed by its partner Astellas Pharma Inc that it would not be seeking marketing approval for their experimental kidney cancer drug, tivozanib, in Europe.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.